Updated Oct 9, 2026 · 04:30 UTC
BMYBristol-Myers Squibb Co.
Health Care · United States · XNYS · pharmaceutical preparations
$59.73−0.20%last session · market closed
Market cap
$122.02b
real-world
Tokenized
$60
<0.001% of the asset
Avg token price
$58.79
Spot volume, 24h
—
Derivatives, 24h
—
Perp open interest
—
In DeFi
—
BMY · Price
Apr 28, 2025low $42.82 · high $68.08 · now $59.10Oct 8, 2026
Earnings
Nasdaq’s earnings calendar
Next earnings
Oct 29
before the open · Sep 2026 quarter · EPS forecast $1.69 (9 analysts)
Last earnings, Jul 30
$2.04 EPS
+28.3% vs $1.59 forecast · Jun 2026 quarter
Real market
Bristol-Myers Squibb Co.
Last close
$59.70
Oct 7
Traded on Oct 7
$662.1m
Price now
$59.73
market closed
Where it trades
24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · — · 0 venues
None yet
Derivatives · — · 0 venues
None yet
Onchain versions
1 token from 1 issuer
wBMYxBacked Assets——By chain
Where the tokens circulate, issuers’ unsold stock taken off
In DeFi
Pools and lending markets that hold these tokens
None found
Business 12 months to Jun 2026 · SEC EDGAR
Results
Revenue
$49.19b
+3% YoY
Net income
$9.28b
19% margin · +84% YoY
EPS, diluted
$4.53
+83% YoY
Cash and balance sheet
Free cash flow
$11.44b
23% of revenue
Net debt
$31.66b
$11.46b cash and securities, $43.12b debt
Diluted shares
2.05b
+0% YoY
Valuation at today’s market cap
P/E
13×
EV / sales
3.1×
enterprise value $153.67b
Free cash flow yield
9.4%
Quarterly
RevenueNet income